A novel TNFRSF1A splice mutation associated with increased nuclear factor KappaB (NF-κB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)

Annals of the Rheumatic Diseases

Volumn 67, Issue 11, 2008, Pages 1589-1595

  Churchman, S M ^a   Church, L D ^a   Savic, S ^b   Coulthard, L R ^a   Hayward, B ^a   Nedjai, B ^c   Turner, M D ^c   Mathews, R J ^a   Baguley, E ^d   Hitman, G A ^c   Gooi, H C ^b   Wood, P M D ^b   Emery, P ^a   McDermott, M F ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN DERIVATIVE; TNFRSF1A PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; WESTERN BLOTTING;

ADOLESCENT; CYTOKINES; DNA MUTATIONAL ANALYSIS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA SPLICE SITES; TRANS-ACTIVATION (GENETICS);

EID: 54349104056     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.078667     Document Type: Article

References (23)

1. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133-44.
2. Tchernitchko D, Chiminqgi M, Galacteros F, Prehu C, Segbena Y, Coulibaly H, et al. Unexpected high frequency of P46L TNFRSF1A allele in sub-Saharan West African populations. Eur J Hum Genet 2005;13:513-15.
3. Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 2001;69:301-14.
4. Dode C, Andre M, Bienvenu T, Hausfater P, Pecheux C, Bienvenu J, et al. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2002;46:2181-8.
5. Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HKP, et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum 2003;48:2632-44.
6. Kusuhara K, Nomura A, Nakao F, Hara T. Tumour necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family. Eur J Pediatr 2004;163:30-2.
7. Stojanov S, Lohse P, McDermott MF, Renner ED, Kery A, Mirakian R, et al. Periodic fever due to a novel TNFRSF1A mutation in a heterozygous Chinese carrier of MEFV E148Q. Rheumatology (Oxford) 2004;43:526- 7.
8. Aganna E, Zeharia A, Hitman GA, Basel-Vanagaite L, Allotey RA, Booth DR, et al. An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2002;46:245-9.
9. Church LD, Churchman SM, Hawkins PN, McDermott MF. Hereditary autoinflammatory disorders and biologies. Springer Semin Immunopathol 2006;27:494-508.
10. Sarrauste de Menthiere C, Terriere S, Pugnere D, Ruiz M, Demaille J, Touitou I. INFEVERS: the registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res 2003;31:282-5.
11. Touitou I, Lesage S, McDermott M, Cuisset L, Hoffman H, Dode C, et al. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004;24:194-8.
12. Kriegel MA, Huffmeier U, Scherb E, Scheidig C, Geiler T, Kalden JR, et al. Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: implications for pathogenesis. Arthritis Rheum 2003;48:2386-8.
13. D'Osualdo A, Ferlito F, Prigione I, Obici L, Meini A, Zulian F, et al. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis - pathogenetic and clinical implications. Arthritis Rheum 2006;54:998-1008.
14. Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM, et al. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 2006;108:1320-7.
15. Nedjai B, Hitman GA, Yousaf N, Chernajovsky Y, Stjernberg S, Pettersson T, et al. Abnormal tumor necrosis factor receptor I cell surface expression and NF-κB activation in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2008;58:273-83.
16. Banner DW, Darcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, et al. Crystal-atructure of the soluble human 55 kD TNF receptor-human TNF-β complex - implications for TNF receptor activation. Cell 1993;73:431-45.
17. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Ann Rev Biophys Biomol Struct 2000;29:291-325.
18. Sali A, Blundell TL. Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol 1993;234:779-815.
19. Nevala H, Karenko L, Stjernberg S, Raatikainen M, Suomalainen H, Lagerstedt A, et al. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever. Arthritis Rheum 2002;46:1061- 6.
20. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, et al. Activation of Ret as a dominant transforming gene by germline mutations of Men2a and Men2b. Science 1995;267:381-3.
21. Simon A, Bodar EJ, van der Hilst JCH, van der Meer JWM, Fiselier TJW, Cuppen M, et al. Beneficial response to interleukin I receptor antagonist in traps. Am J Med 2004;117:208-10.
22. Arkwright PD, McDermottt MF, Houten SM, Frenkel J, Waterhan HR, Aganna E, et al. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept. Clin Exp Immunol 2002;130:484- 8.
23. Mathas S, Johrens K, Joos S, Lietz A, Hummel F, Janz M, et al. Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood 2005;106:4287-93.